MedPath

Fujian Cosunter Pharmaceutical Co.,Ltd.

Fujian Cosunter Pharmaceutical Co.,Ltd. logo
🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Phase I Study of GST-HG151 Tablets in Healthy Volunteers

Phase 1
Conditions
Healthy Volunteers
Interventions
Drug: Placebo
First Posted Date
2022-04-26
Last Posted Date
2022-04-26
Lead Sponsor
Fujian Cosunter Pharmaceutical Co. Ltd
Target Recruit Count
112
Registration Number
NCT05345964
Locations
🇨🇳

Mengchao Hepatpbiliary Hospital of Fujian Medical University, Fujian, Fuzhou, China

Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets

Phase 1
Completed
Conditions
Hepatitis B
Interventions
Drug: GST-HG141 tablets
Drug: Matching Placebos for GST-HG141 tablets
First Posted Date
2021-05-03
Last Posted Date
2022-06-07
Lead Sponsor
Fujian Cosunter Pharmaceutical Co. Ltd
Target Recruit Count
30
Registration Number
NCT04868981
Locations
🇨🇳

The first hospital of Jilin University, Changchun, Jilin, China

Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 Tablets

Phase 1
Conditions
Hepatitis B
Interventions
Drug: GST-HG131 tablets
Drug: Placebo
First Posted Date
2020-08-05
Last Posted Date
2020-09-24
Lead Sponsor
Fujian Cosunter Pharmaceutical Co. Ltd
Target Recruit Count
124
Registration Number
NCT04499443
Locations
🇨🇳

The first hospital of Jilin University, Changchun, Jilin, China

Study on the Tolerance and Pharmacokinetics of GST-HG141 Tablets

Phase 1
Conditions
Hepatitis B
Interventions
Drug: GST-HG141 tablets
Drug: Placebo
First Posted Date
2020-05-13
Last Posted Date
2020-06-04
Lead Sponsor
Fujian Cosunter Pharmaceutical Co. Ltd
Target Recruit Count
104
Registration Number
NCT04386915
Locations
🇨🇳

The first hospital of Jilin University, Changchun, Jilin, China

Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy Evaluation of GST-HG161

Phase 1
Conditions
Solid Tumor
C-Met Mutation-Related Tumors
Interventions
First Posted Date
2020-01-14
Last Posted Date
2020-01-14
Lead Sponsor
Fujian Cosunter Pharmaceutical Co. Ltd
Target Recruit Count
62
Registration Number
NCT04228406
Locations
🇨🇳

Shanghai Oriental Hospital, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath